Live weekly webinars for innovation, R&D and IP professionals
PatSnap answers the hardest questions encountered throughout the innovation life cycle—from creating new inventions to commercialising them.
The tool stores in one place all the information typically consulted by R&D and intellectual property teams—including millions of patents, scientific journals, litigation data, as well as company technology and financial profiles.
Our deep learning algorithms find patterns across these billions of data points, so you get game-changing insights in the blink of an eye.
Get your free demonstration today: www.patsnap.com/contact
Christopher Ralph, Technical Training Expert at PatSnap
In a recent survey by Harvard Business Review, it was revealed that on average, only 23% of participants said they learned about a competitors innovation early enough to respond before it hit the market. Whilst competition is inevitable, there are strategies you can implement to decrease the risk they pose to your business.
Join our upcoming webinar, hosted by Christopher Ralph as we explore how to successfully track the activities of your competitors using patent data. Other themes covered in this webinar include:
• Identifying emerging players in your market
• The benefits of keeping, or bringing your competitor tracking back in-house
• Communicating competitor intelligence to colleagues
• Competitors as opportunities, not just threats.
Modern drug discovery appears in many ways to be well-defined with tried-and-tested approaches to acquire success. However, some research processes often lead to very few new discoveries and sometimes stagnation of an entire research area.
So, does it always have to be this way? One method to re-boot a failing area of research is to employ disruptive chemical methods and thinking to kick-start a process of rejuvenation.
We invite you to our webinar with Roshan Jumnah, Chemical IP data analyst at PatSnap to explore:
- Can we identify the reasons why drug discovery is failing?
- Chemical disruption, its uses, and the impact of this new approach on the pharmaceutical industry
- The ways chemical disruption can reverse failing drug discovery in the future.
Over the last 10 years, China has evolved from a cheap manufacturing engine to one of the worlds largest patent filers. With initiatives like 'Made in China 2025,' we are seeing China set clear goals, moving away from imitation to strategic innovation.
So what does this mean for your business? Should you see China as a threat or an opportunity? And how can you take advantage of this IP and innovation powerhouse in the future? PatSnap is pleased to welcome back Ian Harvey from Tsinghua University, Beijing & Imperial College Business School, London to share how he thinks many businesses should be managing the opportunities China's innovation holds.
Other themes explored in this webinar include:
- What Chinese innovation means for your intellectual property
- How to track current and emerging competitors in the market
- What IP litigation in China is really like
Conducting thorough freedom to operate (FTO) searches is an essential part of R&D and IP strategies for many companies. Outsourcing searches to external professionals can be highly effective but can come with its own list of risks and costs.
So what are the ways you can lay the most effective freedom to operate searching foundations, before contacting a legal professional for their advice?
PatSnap will be joined patent attorney, and Amazon bestselling author Dylan Adams, for an insightful webinar into how you can lay the most effective groundwork throughout your FTO search, whether you're using an in-house counsel team or an external law firm.
This webinar will explore key themes including:
- Where to get started with an FTO search
- How to effectively communicate your invention to an attorney
- What an attorney needs to make their searching faster and more effective
Technology transfer offices are often seen as the facilitators of innovation between academic institutions and industry. However, they have a massive responsibility to transfer the wealth of innovation from within universities to the commercial world, in the most timely and cost-efficient way possible. Does the current Intellectual Property system facilitate their requirements, or can it sometimes hinder innovation?
In this webinar, we will be joined by Jeremy Holmes, Head of intellectual property at Imperial Innovations, the technology transfer office of Imperial College, London. Jeremy will be talking about the ingredients needed for a successful partnership, and future, between technology transfers and commercial world. We will also be discussing:
• The power behind freedom to operate when making judgements on the commercial opportunity of an idea
• Why education of IP is so important, for academics & business professionals
• How to find the balance between freedom & creativity, with the need for intellectual property protection
• Whether you need patents to have a successful university spin out.
Although intellectual property is often a large asset to any innovative company it can be hard to justify to senior management the costs that come with it. Patents especially, need to be renewed yearly and also can become very costly in the case of infringement that leads to litigation.
So how can you explain to your senior management that your IP is a key essential asset? This is what Nick Pay and Pete Hotten will be discussing in this webinar.
You will learn:
- How to best showcase the value of your IP
- The language you should use with senior management
- What steps can you take to integrate IP into your whole business
Intellectual property is fast becoming one of the largest, and most valuable items on many organisations balance sheet. These assets can bring to light considerable risks, and opportunities, during M&A.
By looking at the IP portfolio of an organisation, you can get an idea of whether you're strengthening, or weakening your market position and which assets will be the most valuable after the M&A.
In this webinar, we'll be looking at the role IP plays in mergers and acquisitions, as well as:
- What kind of due diligence to consider when looking into patent portfolios
- How to use intellectual property to highlight, and avoid risks during M&A
- How to make better decisions when navigating risks and opportunities
The primary reason why people register their IP - including trademarks patents - is to protect their ideas from being used and monetized by others. Companies across the world spend trillions of dollars on research and patent thousands of new technologies each year, so why would you ever need IP insurance?
We see dozens of cases each year where companies and individuals are claiming infringement upon their IP and that's when IP insurance comes into play.
PatSnap is joined by Erik Alsegard, IP Practice Leader and Lewis Parle, In-House Solicitor and IP Underwriter, from CFC Underwriting to discuss the whys and hows of IP Insurance.
Join this webinar to learn about the risks of IP, if you should consider insurance and what are the pros and cons of the options available to you when it comes to protecting your Intellectual Property assets.
The term innovation can refer to various stages within a product development cycle, and an invention created in this process can be protected by various forms of intellectual property. Most inventions are created to solve and address consumer needs and problems. To do that job, products enter the market, creating opportunities for the business or the inventor who owns it. A businesses’ IP strategy plays an important role in the success of a new product by ensuring competitive advantage in the market, for now and the future.
However, IP protection can often be seen as an output of product development, leaving the organisation open to risk—whether it's in a new or an existing market. So how can you align IP protection with your invention creation to ensure your IP team is involved at the most effective points throughout the product development process? Too early could mean a slower time to market, and too late could mean lost opportunities in the market.
In this webinar, we’ll be discussing how your organisation can mitigate risk, by aligning your IP and innovation strategy. We will also be looking at:
- Examples of successful organisations who have aligned their IP and innovation
- Intellectual property & open innovation
- Why IP should be a part of the innovation process, not an event
Patent searching is something most IP counsel is very familiar with. It's your day to day when looking at Freedom to Operate, competitive analysis and portfolio management.
However, it can be hard to predict what you need in a search when you are not a technical expert. In this webinar, we will teach you how to construct the most effective searches using boolean and a few other tips and tricks on how to ensure you include all the technical detail you need.
Many companies have influence in markets because they make essential products. Think about the products all around us the metals, plastics and various other materials that make up our world. We can see how a change in manufacturing processes or supply could influence the whole industry.
We are joined by Dr.Shafiq Kabir, Chief Innovation Officer at Smoltek AB, to learn how companies who rely on only Intellectual Property are working to change the market. Smoltek specialises in nanomaterials and their applications and brings together industry, intellectual property and manufacturers together.
This is essential viewing for anyone interested in nanomaterials/nanotechnology, IP, licensing and market penetration.